US 12269820
Piperazine substituted indazole compounds as inhibitors of PARG
granted A61PA61P35/00
Quick answer
US patent 12269820 (Piperazine substituted indazole compounds as inhibitors of PARG) held by IDEAYA Biosciences, Inc. expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- IDEAYA Biosciences, Inc.
- Grant date
- Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P35/00